Trunk control exercises and mirror therapy to improve balance and posture in Parkinson's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two rehabilitation approaches for Parkinson's disease: trunk control exercises and mirror therapy. Participants are adults aged 50-70 with moderate Parkinsonism (Hoehn and Yahr stages 1-3) who are on a stable medication regimen and do not have cognitive impairment or significant dyskinesias. The trial uses a structured program to prompt normal movement through visual illusion and neuromuscular training, aiming to improve balance and posture. Outcomes will inform whether combining these approaches offers a practical benefit for motor function in PD. Safety considerations include screening for cardiovascular stability and recent epilepsy or trauma history.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* • 50-70 age(Bomasang-Layno et al., 2015)

  * Both genders (Bomasang-Layno et al., 2015)
  * Patient with grade 1,2,3 Parkinsonism (according to Hoehn and Yahr scale)
  * Patient taking fixed dose of medicines
  * No cognitive impairment (according to Mini-Mental scale 24-30 scoring) (Capecci et al., 2014)
  * The patient was able to get out of chairs and beds without assistance (Hoffmann et al., 2016).
  * Individuals without significant dyskinesias or "on-off" periods.(Lötzke et al., 2015)

Exclusion Criteria:

* • Patient having any recent episode of epilepsy(Bomasang-Layno et al., 2015)

  * Patient has had any recent trauma. (Hong et al., 2009)
  * Individuals free from chronic diseases such as unstable cardiovascular disease that could compromise their safety during training or testing (Hoffmann et al., 2016).

Where it's running

• Nimra Nadeem
  Lahore, Punjab Province, Pakistan Recruiting

Study contacts

• Principal investigator: Nimra Nadeem, MS (NMPT) — University of Lahore
• Study coordinator: Ishaq Ahmed, PHD
• Email: ishaq.ahmed@uipt.uol.edu.pk
• Phone: 0334 4066 463

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder

  This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.

  Recruiting Cambridge University Hospitals NHS Foundation Trust · Cambridge · NCT07882108

• Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment

  This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07868614

• Mental imagery with self-regulation to help daily activities in Parkinson's disease

  This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.

  Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT07860294

• Real-world experiences of Inbrija for Parkinson's OFF episodes

  This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.

  Recruiting Merz Pharmaceuticals GmbH · Altmünster and 1 other locations · NCT07797790

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Test of RO7568282 in early Parkinson's disease

  This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.

  Recruiting at 4 sites Phase 2 Hoffmann-La Roche · Boca Raton, Florida and 3 other locations · NCT07781644

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.